Literature DB >> 9776209

The collagen-platelet interaction.

M J Barnes1, C G Knight, R W Farndale.   

Abstract

Collagen-platelet interaction, occurring in hemostasis but also a cause of thrombosis, is a two-step process of adhesion and activation involving the sequential recognition of distinct receptors. Adhesion involves first the reversible recognition of collagen-bound von Willebrand factor by the platelet receptor complex Gp Ib/IX/V, followed by direct interaction between collagen and the platelet integrin receptor alpha2beta1, which binds to specific sequences in collagen in which the GER motif appears important. Platelet activation then follows from the recognition by the receptor Gp VI of GPP* sequences in collagen, culminating in signalling events unique to collagen as a platelet agonist: Gp VI leads via the novel platelet Fc receptor gamma-chain to p72syk and phospholipase Cgamma2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776209     DOI: 10.1097/00062752-199809000-00002

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  17 in total

1.  Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.

Authors:  Gavin E Jarvis; Ben T Atkinson; Daniel C Snell; Steve P Watson
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

2.  Aspirin resistance and diabetes mellitus.

Authors:  R Ajjan; R F Storey; P J Grant
Journal:  Diabetologia       Date:  2008-03       Impact factor: 10.122

3.  Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI.

Authors:  J Asselin; C G Knight; R W Farndale; M J Barnes; S P Watson
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome.

Authors:  Y Sasahara; S Kumaki; Y Ohashi; M Minegishi; H Kano; F Bessho; S Tsuchiya
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

5.  Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets.

Authors:  Hong Chen; Mark L Kahn
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

6.  The platelet: life on the razor's edge between hemorrhage and thrombosis.

Authors:  Barry S Coller
Journal:  Transfusion       Date:  2014-08-05       Impact factor: 3.157

7.  Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans.

Authors:  Jochen Graff; Ute Klinkhardt; Dagmar Westrup; Carl M Kirchmaier; Hans Klaus Breddin; Sebastian Harder
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

8.  Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.

Authors:  Kamala Bhavaraju; Soochong Kim; James L Daniel; Satya P Kunapuli
Journal:  Eur J Pharmacol       Date:  2007-11-17       Impact factor: 4.432

9.  Glycoprotein VI/Fc receptor gamma chain-independent tyrosine phosphorylation and activation of murine platelets by collagen.

Authors:  Gavin E Jarvis; Denise Best; Steve P Watson
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

10.  Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.

Authors:  Daniel C Snell; Valerie Schulte; Gavin E Jarvis; Kanako Arase; Daiju Sakurai; Takashi Saito; Steve P Watson; Bernhard Nieswandt
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.